According to Citius Pharmaceuticals latest financial reports the cash on hand of CTXR is $26.48M, an decrease of -36.51% to 2022. At the end of 2022 company had $41.71M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $26.48M | -36.51% |
2022 | $41.71M | -40.47% |
2021 | $70.07M | 405.59% |
2020 | $13.86M | 75.58% |
2019 | $7.89M | -14.05% |
2018 | $9.18M | - |